Raymond James Financial’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$217K Buy
59,502
+8,568
+17% +$31.2K ﹤0.01% 4445
2025
Q1
$97.8K Buy
50,934
+6,186
+14% +$11.9K ﹤0.01% 4503
2024
Q4
$85K Buy
+44,748
New +$85K ﹤0.01% 4502